World’s first bedside genetic test proves effective: Canadian heart researchers’ pioneering “proof-of-concept” study holds promising implications for all areas of medicine

Tailored anti-platelet therapy, made possible through a novel point-of-care genetic test, optimizes treatment for patients who carry a common genetic variant, researchers at the University of Ottawa Heart Institute (UOHI) have found.

Share This